SSY Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2005 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
29 Apr 25	BuyHK$2,954,998	China Pharmaceutical Company Limited	Company	1,000,000	HK$2.95
16 Apr 25	BuyHK$4,135,180	China Pharmaceutical Company Limited	Company	1,400,000	HK$2.95
15 Apr 25	BuyHK$1,758,617	Jiguang Qu	Individual	580,000	HK$3.03
11 Apr 25	BuyHK$2,408,961	Jiguang Qu	Individual	800,000	HK$3.01
09 Apr 25	BuyHK$906,331	China Pharmaceutical Company Limited	Company	300,000	HK$3.02
07 Apr 25	BuyHK$18,034,818	China Pharmaceutical Company Limited	Company	6,000,000	HK$3.01
03 Apr 25	BuyHK$10,065,294	China Pharmaceutical Company Limited	Company	3,000,000	HK$3.36
01 Apr 25	BuyHK$4,723,885	Jiguang Qu	Individual	1,400,000	HK$3.37
01 Apr 25	BuyHK$10,088,111	China Pharmaceutical Company Limited	Company	3,000,000	HK$3.36
31 Mar 25	BuyHK$8,935,078	China Pharmaceutical Company Limited	Company	2,800,000	HK$3.19
21 Feb 25	SellHK$1,206,731	UBS Asset Management AG	Company	372,000	HK$3.24
20 Feb 25	BuyHK$660,310	UBS Asset Management AG	Company	198,000	HK$3.33
18 Feb 25	SellHK$1,451,062	UBS Asset Management AG	Company	448,204	HK$3.24
08 Jan 25	BuyHK$1,631,500	China Pharmaceutical Company Limited	Company	500,000	HK$3.26
07 Jan 25	BuyHK$2,002,141	China Pharmaceutical Company Limited	Company	600,000	HK$3.34
06 Jan 25	BuyHK$2,033,039	China Pharmaceutical Company Limited	Company	600,000	HK$3.39
03 Jan 25	BuyHK$2,225,388	China Pharmaceutical Company Limited	Company	660,000	HK$3.37
26 Nov 24	BuyHK$4,537,654	Jiguang Qu	Individual	1,300,000	HK$3.49
20 Nov 24	BuyHK$1,551,921	Jiguang Qu	Individual	400,000	HK$3.88
19 Nov 24	BuyHK$3,395,073	Jiguang Qu	Individual	900,000	HK$3.77
15 Nov 24	BuyHK$3,807,000	China Pharmaceutical Company Limited	Company	1,000,000	HK$3.81
14 Nov 24	BuyHK$3,816,599	China Pharmaceutical Company Limited	Company	1,000,000	HK$3.82
30 Oct 24	BuyHK$2,900,431	China Pharmaceutical Company Limited	Company	780,000	HK$3.72
29 Oct 24	BuyHK$4,803,585	China Pharmaceutical Company Limited	Company	1,280,000	HK$3.75
21 Oct 24	BuyHK$3,118,161	China Pharmaceutical Company Limited	Company	800,000	HK$3.90
14 Oct 24	BuyHK$4,137,300	China Pharmaceutical Company Limited	Company	1,000,000	HK$4.14
08 Oct 24	BuyHK$3,486,560	China Pharmaceutical Company Limited	Company	800,000	HK$4.36
04 Oct 24	BuyHK$1,326,209	China Pharmaceutical Company Limited	Company	300,000	HK$4.42
25 Sep 24	BuyHK$3,831,703	China Pharmaceutical Company Limited	Company	1,000,000	HK$3.83
24 Sep 24	BuyHK$4,756,777	Jiguang Qu	Individual	1,230,000	HK$3.87
23 Sep 24	BuyHK$3,141,582	China Pharmaceutical Company Limited	Company	820,000	HK$3.83
11 Sep 24	BuyHK$9,496,757	China Pharmaceutical Company Limited	Company	2,500,000	HK$3.80
10 Sep 24	BuyHK$3,849,600	China Pharmaceutical Company Limited	Company	1,000,000	HK$3.85
09 Sep 24	BuyHK$5,002,920	China Pharmaceutical Company Limited	Company	1,300,000	HK$3.85
05 Sep 24	BuyHK$8,597,376	China Pharmaceutical Company Limited	Company	2,200,000	HK$3.91
04 Sep 24	BuyHK$3,906,499	China Pharmaceutical Company Limited	Company	1,000,000	HK$3.91
03 Sep 24	BuyHK$3,919,497	China Pharmaceutical Company Limited	Company	1,000,000	HK$3.92
02 Sep 24	BuyHK$7,746,206	China Pharmaceutical Company Limited	Company	2,000,000	HK$3.87
02 Sep 24	BuyHK$1,524,441	Jiguang Qu	Individual	400,000	HK$3.81
30 Aug 24	BuyHK$9,141,498	China Pharmaceutical Company Limited	Company	2,350,000	HK$3.89
21 Aug 24	BuyHK$20,968,467	Sichuan Kelun Industry Group CO., LTD.	Company	5,930,000	HK$3.54

Insider Trading Volume

Insider Buying: 2005 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2005?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	315,634,000	10.7%
Institutions	557,902,695	18.9%
General Public	573,312,690	19.4%
Private Companies	1,504,264,000	51%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
29.7%	China Pharmaceutical Company Limited	875,488,000	HK$2.6b	2.42%	no data
21.3%	Sichuan Kelun Industry Group CO., LTD.	628,776,000	HK$1.9b	0%	no data
9.87%	Jiguang Qu	291,218,000	HK$859.1m	0.68%	no data
9%	UBS Asset Management AG	265,496,063	HK$783.2m	-10.2%	0.01%
1.86%	The Vanguard Group, Inc.	54,940,729	HK$162.1m	0.69%	no data
1.06%	Dimensional Fund Advisors LP	31,352,960	HK$92.5m	-0.31%	no data
0.83%	Penghua Fund Management Co., Ltd.	24,486,000	HK$72.2m	0%	0.05%
0.83%	Xuejun Su	24,416,000	HK$72.0m	0%	no data
0.79%	BlackRock, Inc.	23,194,375	HK$68.4m	1.59%	no data
0.75%	Norges Bank Investment Management	22,159,717	HK$65.4m	0%	no data
0.72%	Bosera Asset Management Co., Ltd.	21,354,000	HK$63.0m	0%	0.03%
0.71%	Fidelity International Ltd	21,018,325	HK$62.0m	88.8%	no data
0.66%	UBS SDIC Fund Management Co., Ltd.	19,364,000	HK$57.1m	0%	0.18%
0.33%	Nordea Investment Management, AB	9,649,070	HK$28.5m	0%	no data
0.27%	China Asset Management Co. Ltd.	7,825,127	HK$23.1m	-9.61%	no data
0.23%	E Fund Management Co., Ltd.	6,772,000	HK$20.0m	0%	no data
0.21%	GF Fund Management Co., Ltd.	6,060,000	HK$17.9m	0%	no data
0.2%	State Street Global Advisors, Inc.	5,946,763	HK$17.5m	32.8%	no data
0.18%	Fullgoal Fund Management Co. Ltd.	5,428,000	HK$16.0m	0%	0.01%
0.18%	American Century Investment Management Inc	5,178,000	HK$15.3m	1.85%	no data
0.14%	Hwabao WP Fund Management Co., Ltd	4,106,000	HK$12.1m	0%	0.01%
0.11%	Invesco Ltd.	3,252,000	HK$9.6m	-16.8%	no data
0.098%	Border To Coast Pensions Partnership Limited	2,894,000	HK$8.5m	0%	0.01%
0.091%	China Southern Asset Management Co., Ltd.	2,672,000	HK$7.9m	0%	no data
0.078%	Nordea Fund Management	2,310,000	HK$6.8m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/02 11:01
End of Day Share Price	2025/05/02 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SSY Group Limited is covered by 21 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Derrick Sun	BNP Paribas Securities (Asia)
Ying Shao	BofA Global Research
Yanyin Zhu	China International Capital Corporation Limited